摘要
目的分析探讨依达拉奉在急性脑梗塞治疗中的临床价值。方法选择我院神经内科2017年4月至2019年4月收治的160例急性脑梗死患者作为研究对象,采用随机数表法分为对照组(80例,予以一般基础治疗)和研究组(80例,在一般基础治疗上再予以依达拉奉治疗),对两组患者的治疗效果、治疗前后的神经功能(NIHSS评分)和日常生活能力(ADL评分)进行对比分析。结果相较于对照组,研究组患者的治疗总有效率明显更高,治疗后的NIHSS评分更低、ADL评分更高,差异显著(P<0.05),均具有统计学意义。结论在急性脑梗塞治疗中,应用依达拉奉具有良好的治疗效果,能够提高患者的治疗总有效率,并良好地改善患者的神经功能和日常生活能力,具有较好的临床价值。
Objective To analyze the clinical value of edaravone in the treatment of acute cerebral infarction.Methods A total of 160 patients with acute cerebral infarction admitted to our Department of Neurology from April 2017 to April 2019 were enrolled in the study.The patients were randomly divided into the control group(80 cases received general basic treatment)and study group(80 cases received edaravone treatment on general basic treatment).The therapeutic effects,neurological function(NIHSS score)and daily living ability(ADL score)before and after treatment were compared.Results Compared with the control group,the total effective rate of the study group was significantly higher.The NIHSS score was lower and the ADL score was higher after treatment(P<0.05),both of which were statistically significant.Conclusion In the treatment of acute cerebral infarction,the application of edaravone has a good therapeutic effect,can improve the total effective rate of treatment,and improve the patient’s nerve function and daily living ability,and has good clinical value.
作者
姚利民
马丽
YAO Li-min;MA Li(Changchun People’s Hospital,Changchun,Jilin 130051)
出处
《智慧健康》
2019年第22期179-180,共2页
Smart Healthcare
关键词
依达拉奉
急性脑梗塞
临床价值
Edaravone
Acute cerebral infarction
Clinical value